Countagen provides GeneAbacus, a PCR-free genotyping technology that enables rapid and precise analysis of gene editing efficiency and specificity using padlock probes and rolling circle amplification. This solution addresses the delays and inaccuracies of traditional genotyping methods, allowing researchers to obtain reliable results in-house within five hours.
Funding
$1.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional gene editing validation methods are slow, often outsourced, require target-by-target optimization, and may lack single-nucleotide precision, creating bottlenecks in the development of cell and gene therapies. Researchers face delays and challenges in accurately assessing gene editing efficiency and specificity.
Solution
Countagen's GeneAbacus is a PCR-free genotyping technology that enables rapid and precise analysis of gene editing outcomes. Using padlock probes and rolling circle amplification, GeneAbacus delivers single-nucleotide precision, allowing researchers to confidently validate gene edits in-house. The technology streamlines the validation process, providing actionable gene editing efficiency analysis within five hours. GeneAbacus integrates seamlessly into existing laboratory workflows and requires no target-specific optimization.
Target Audience
The primary target audience includes researchers and developers in the cell and gene therapy field who require rapid, precise, and reliable gene editing validation.
Features
- PCR-free assay based on padlock probes and rolling circle amplification
- Single-nucleotide precision for accurate assessment of gene editing outcomes
- Rapid turnaround time, delivering results in-house within five hours
- Simplified workflow that integrates into existing laboratory setups
- No target-by-target optimization required, saving time and resources
- Compatible with standard laboratory equipment